BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1190025	C[C@@H](O)[C@H](NC(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(c1F)-c1ccccc1Cl	InChI=1S/C33H29ClFN5O4/c1-18(41)26-16-40(29-12-11-21(13-25(26)29)22-14-36-20(3)37-15-22)17-30(43)39-32(19(2)42)33(44)38-28-10-6-8-24(31(28)35)23-7-4-5-9-27(23)34/h4-16,19,32,42H,17H2,1-3H3,(H,38,44)(H,39,43)/t19-,32+/m1/s1	GYQUUSDHPABGRW-WHUARKNTSA-N	563123	(2S,3R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetamido)-N- (2'-chloro-2- fluorobiphenyl-3- yl)-3- hydroxybutanamide::US11407738, Cmpd No. 500	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563123&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149134	472624665							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190026	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(O[C@@H]2CO[C@@H]3[C@H](O)CO[C@H]23)nc1	InChI=1S/C39H34ClF2N5O7/c1-20(48)27-16-46(30-10-9-21(11-26(27)30)22-13-43-39(44-14-22)54-33-19-53-36-32(49)18-52-37(33)36)17-34(50)47-15-23(41)12-31(47)38(51)45-29-8-4-6-25(35(29)42)24-5-2-3-7-28(24)40/h2-11,13-14,16,23,31-33,36-37,49H,12,15,17-19H2,1H3,(H,45,51)/t23-,31+,32-,33-,36-,37-/m1/s1	YTEMJPGCGGZQBW-NUSUXSJVSA-N	386403	(2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6- hydroxyhexahydrofuro [3,2-b]furan-3- yl)oxy)pyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 333::US10822352, Comp No. 333::US11407738, Cmpd No. 501	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386403&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623797	404855560							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190027	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(O[C@@H]2CO[C@@H]3[C@H](O)CO[C@H]23)nc1	InChI=1S/C32H30BrFN6O7/c1-16(41)21-12-39(13-28(43)40-11-19(34)8-23(40)31(44)38-27-4-2-3-26(33)37-27)22-6-5-17(7-20(21)22)18-9-35-32(36-10-18)47-25-15-46-29-24(42)14-45-30(25)29/h2-7,9-10,12,19,23-25,29-30,42H,8,11,13-15H2,1H3,(H,37,38,44)/t19-,23+,24-,25-,29-,30-/m1/s1	XNEOEGQFBKMSBQ-QBRLCXGLSA-N	386404	(2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6- hydroxyhexahydrofuro [3,2-b]furan-3- yl)oxy)pyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 334::US10287301, Compound 337::US10822352, Comp No. 334::US11407738, Cmpd No. 502	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386404&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623765	404855561							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190028	COC1CO[C@@H]2[C@@H](CO[C@H]12)Oc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C40H36ClF2N5O7/c1-21(49)28-17-47(31-11-10-22(12-27(28)31)23-14-44-40(45-15-23)55-34-20-54-37-33(52-2)19-53-38(34)37)18-35(50)48-16-24(42)13-32(48)39(51)46-30-9-5-7-26(36(30)43)25-6-3-4-8-29(25)41/h3-12,14-15,17,24,32-34,37-38H,13,16,18-20H2,1-2H3,(H,46,51)/t24-,32+,33?,34-,37-,38-/m1/s1	XDEIEXBZTNVABE-ZWRIARICSA-N	563126	(2S,4R)-1-(2-(3- acetyl-5-(2- ((3R,3aR,6R,6aR)- 6- methoxyhexahydro- furo[3,2-b]furan-3- yloxy)pyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 503	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563126&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			154627628	472624668							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190029	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2)S(F)(F)(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24F6N6O3S/c1-15(40)26-22-8-17(18-11-34-16(2)35-12-18)6-7-23(22)39(37-26)14-25(41)38-13-19(28)9-24(38)27(42)36-20-4-3-5-21(10-20)43(29,30,31,32)33/h3-8,10-12,19,24H,9,13-14H2,1-2H3,(H,36,42)/t19-,24+/m1/s1	IHWSMKBYJFYDKG-DVECYGJZSA-N	563127	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(3-(pentafluoro- $#9633;6- sulfanyl)phenyl)pyrro- lidine-2- carboxamide::US11407738, Cmpd No. 504	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563127&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149127	472624669							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190030	C[C@@H](O)[C@H](NC(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C26H25BrN6O4/c1-14(34)20-12-33(21-8-7-17(9-19(20)21)18-10-28-16(3)29-11-18)13-24(36)32-25(15(2)35)26(37)31-23-6-4-5-22(27)30-23/h4-12,15,25,35H,13H2,1-3H3,(H,32,36)(H,30,31,37)/t15-,25+/m1/s1	QEZNEOKARJXDLL-BZQUYTCOSA-N	563128	(2S,3R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetamido)-N- (6-bromopyridin-2- yl)-3- hydroxybutanamide::US11407738, Cmpd No. 505	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563128&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624028	472624670							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190031	C[C@@H](O)[C@H](N(C)C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(c1F)-c1ccccc1Cl	InChI=1S/C34H31ClFN5O4/c1-19(42)27-17-41(30-13-12-22(14-26(27)30)23-15-37-21(3)38-16-23)18-31(44)40(4)33(20(2)43)34(45)39-29-11-7-9-25(32(29)36)24-8-5-6-10-28(24)35/h5-17,20,33,43H,18H2,1-4H3,(H,39,45)/t20-,33+/m1/s1	SLFZDJWTFZKJDK-BPJXYHRLSA-N	563129	(2S,3R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1-yl)- N- methylacetamido)- N-(2'-chloro-2- fluorobiphenyl-3- yl)-3- hydroxybutanamide::US11407738, Cmpd No. 506	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563129&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623740	472624671							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190032	CC(=O)c1cn(CC(=O)NC(CC(F)(F)F)C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H26ClF4N5O3/c1-18(44)25-16-43(29-11-10-20(12-24(25)29)21-14-39-19(2)40-15-21)17-30(45)41-28(13-33(36,37)38)32(46)42-27-9-5-7-23(31(27)35)22-6-3-4-8-26(22)34/h3-12,14-16,28H,13,17H2,1-2H3,(H,41,45)(H,42,46)	FIMDOEHMIWFHCK-UHFFFAOYSA-N	563130	2-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetamido)-N- (2'-chloro-2- fluorobiphenyl-3- yl)-4,4,4- trifluorobutanamide::US11407738, Cmpd No. 507	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563130&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623894	472624672							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190033	COC1CO[C@@H]2[C@@H](CO[C@H]12)Oc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C33H32BrFN6O7/c1-17(42)22-13-40(14-29(43)41-12-20(35)9-24(41)32(44)39-28-5-3-4-27(34)38-28)23-7-6-18(8-21(22)23)19-10-36-33(37-11-19)48-26-16-47-30-25(45-2)15-46-31(26)30/h3-8,10-11,13,20,24-26,30-31H,9,12,14-16H2,1-2H3,(H,38,39,44)/t20-,24+,25?,26-,30-,31-/m1/s1	CGAPZQCWVTTXAD-ZWFRTXBUSA-N	563131	(2S,4R)-1-(2-(3- acetyl-5-(2- ((3R,3aR,6R,6aR)- 6- methoxyhexahydro- furo[3,2-b]furan-3- yloxy)pyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 508	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563131&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135179341	472624673							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190034	COC(=O)C[C@H]1CCCN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C23H25N5O4/c1-14(29)23-19-9-16(17-11-24-15(2)25-12-17)6-7-20(19)28(26-23)13-21(30)27-8-4-5-18(27)10-22(31)32-3/h6-7,9,11-12,18H,4-5,8,10,13H2,1-3H3/t18-/m1/s1	ZVAOSHMTCJZVGY-GOSISDBHSA-N	563132	(R)-methyl 2-(1-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidin- 2-yl)acetate::US11407738, Cmpd No. 509	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563132&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149155	472624674							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190035	CC(=O)c1nn(CC(=O)N2CCC[C@@H]2CC(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C22H23N5O4/c1-13(28)22-18-8-15(16-10-23-14(2)24-11-16)5-6-19(18)27(25-22)12-20(29)26-7-3-4-17(26)9-21(30)31/h5-6,8,10-11,17H,3-4,7,9,12H2,1-2H3,(H,30,31)/t17-/m1/s1	JEPOGJJUOOBBIT-QGZVFWFLSA-N	563133	(R)-2-(1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidin- 2-yl)acetic acid::US11407738, Cmpd No. 510	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563133&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149118	472624675							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190036	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3c(cccc3c2)S(O)(=O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H27FN6O6S/c1-17(39)30-25-11-19(21-13-33-18(2)34-14-21)6-9-26(25)38(36-30)16-29(40)37-15-22(32)12-27(37)31(41)35-23-7-8-24-20(10-23)4-3-5-28(24)45(42,43)44/h3-11,13-14,22,27H,12,15-16H2,1-2H3,(H,35,41)(H,42,43,44)/t22-,27+/m1/s1	NEKIBWCPAZONML-AMGIVPHBSA-N	563134	6-((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamido)naph- thalene-1-sulfonic acid::US11407738, Cmpd No. 511	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563134&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623915	472624676							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190037	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(CC2)c2ccc(cn2)C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H33FN8O5/c1-18(42)30-25-11-20(22-14-34-19(2)35-15-22)3-5-26(25)41(38-30)17-29(43)40-16-23(33)12-27(40)31(44)37-24-7-9-39(10-8-24)28-6-4-21(13-36-28)32(45)46/h3-6,11,13-15,23-24,27H,7-10,12,16-17H2,1-2H3,(H,37,44)(H,45,46)/t23-,27+/m1/s1	NGQJULXZKMUITQ-KCWPFWIISA-N	563135	6-(4-((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamido)piperi- din-1-yl)nicotinic acid::US11407738, Cmpd No. 512	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563135&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623767	472624677							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190038	COC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C22H22FN5O4/c1-12(29)21-17-6-14(15-8-24-13(2)25-9-15)4-5-18(17)28(26-21)11-20(30)27-10-16(23)7-19(27)22(31)32-3/h4-6,8-9,16,19H,7,10-11H2,1-3H3/t16-,19+/m1/s1	NWHASOPBNJBUHV-APWZRJJASA-N	563136	(2S,4R)-methyl 1- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxylate::US11407738, Cmpd No. 513	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563136&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149116	472624678							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190039	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C21H20FN5O4/c1-11(28)20-16-5-13(14-7-23-12(2)24-8-14)3-4-17(16)27(25-20)10-19(29)26-9-15(22)6-18(26)21(30)31/h3-5,7-8,15,18H,6,9-10H2,1-2H3,(H,30,31)/t15-,18+/m1/s1	CNHARIWSCQSUJS-QAPCUYQASA-N	563137	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxylic acid::US11407738, Cmpd No. 514	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563137&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623788	472624679							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190040	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)OCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H24ClF2N5O4/c1-15(37)27-21-8-17(19-10-32-16(2)33-11-19)6-7-23(21)36(34-27)13-25(38)35-12-20(30)9-24(35)28(39)40-14-18-4-3-5-22(29)26(18)31/h3-8,10-11,20,24H,9,12-14H2,1-2H3/t20-,24+/m1/s1	YGPBLSXYHYFIGW-YKSBVNFPSA-N	563138	(2S,4R)-3-chloro-2- fluorobenzyl 1-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxylate::US11407738, Cmpd No. 515	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563138&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149190	472624680							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190041	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)SCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H24ClF2N5O3S/c1-15(37)27-21-8-17(19-10-32-16(2)33-11-19)6-7-23(21)36(34-27)13-25(38)35-12-20(30)9-24(35)28(39)40-14-18-4-3-5-22(29)26(18)31/h3-8,10-11,20,24H,9,12-14H2,1-2H3/t20-,24+/m1/s1	CMPHKMPLWROICC-YKSBVNFPSA-N	563139	(2S,4R)-S-3-chloro- 2-fluorobenzyl 1- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carbothioate::US11407738, Cmpd No. 516	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563139&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623829	472624681							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190042	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=S)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25ClF2N6O2S/c1-15(38)27-21-8-17(19-11-32-16(2)33-12-19)6-7-23(21)37(35-27)14-25(39)36-13-20(30)9-24(36)28(40)34-10-18-4-3-5-22(29)26(18)31/h3-8,11-12,20,24H,9-10,13-14H2,1-2H3,(H,34,40)/t20-,24+/m1/s1	RXGNAFLJBMNOIW-YKSBVNFPSA-N	563140	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-4- fluoropyrrolidine-2- carbothioamide::US11407738, Cmpd No. 517	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563140&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623762	472624682							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190043	CC(=O)c1nn2CC(=O)N3C[C@H](F)C[C@H]3C(=O)NCc3cc(cc(Cl)c3F)\C=C/CCCCCCCCCNc3ncc(cn3)-c3ccc2c1c3	InChI=1S/C38H42ClF2N7O3/c1-24(49)36-30-17-26-12-13-32(30)48(46-36)23-34(50)47-22-29(40)18-33(47)37(51)43-19-27-15-25(16-31(39)35(27)41)11-9-7-5-3-2-4-6-8-10-14-42-38-44-20-28(26)21-45-38/h9,11-13,15-17,20-21,29,33H,2-8,10,14,18-19,22-23H2,1H3,(H,43,51)(H,42,44,45)/b11-9-/t29-,33+/m1/s1	LDXWAUBPZPZXGA-CKUKAELUSA-N	563141	(52S,54R,Z)-23- acetyl-95-chloro- 54,96-difluoro-21H- 7,21-diaza-2(5,1)- indazola-1(5,2)- pyrimidina-5(1,2)- pyrrolidina-9(1,3)- benzenacyclohenico- saphan-10-ene- 4,6-dione::US11407738, Cmpd No. 518	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563141&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135179093	472624683							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190044	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccc(c(F)c2)-c2ccc3scnc3c2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C37H30F2N8O3S/c1-20-9-34-40-15-25(16-47(34)43-20)23-4-7-31-28(11-23)36(21(2)48)44-46(31)18-35(49)45-17-26(38)13-32(45)37(50)41-14-22-3-6-27(29(39)10-22)24-5-8-33-30(12-24)42-19-51-33/h3-12,15-16,19,26,32H,13-14,17-18H2,1-2H3,(H,41,50)/t26-,32+/m1/s1	RAKIVVAUCBQYMJ-DICHSLLOSA-N	563142	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(3- (benzo[d]thiazol-5- yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 519	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563142&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			154627637	472624684							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190045	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccc(c(F)c2)-c2ccc3scnc3c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H29F2N7O3S/c1-19(45)34-27-10-22(24-14-38-20(2)39-15-24)4-7-30(27)44(42-34)17-33(46)43-16-25(36)12-31(43)35(47)40-13-21-3-6-26(28(37)9-21)23-5-8-32-29(11-23)41-18-48-32/h3-11,14-15,18,25,31H,12-13,16-17H2,1-2H3,(H,40,47)/t25-,31+/m1/s1	YHIKBAFAHSPQES-NJHZRGNWSA-N	563143	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- (benzo[d]thiazol-5- yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 520	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563143&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			154627625	472624685							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190046	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)S(=O)(=O)NC2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H32ClF2N7O5S/c1-19(47)35-28-12-21(22-15-40-20(2)41-16-22)6-11-31(28)46(43-35)18-33(48)45-17-23(38)13-32(45)36(49)42-30-5-3-4-26(34(30)39)27-14-25(9-10-29(27)37)52(50,51)44-24-7-8-24/h3-6,9-12,14-16,23-24,32,44H,7-8,13,17-18H2,1-2H3,(H,42,49)/t23-,32+/m1/s1	KFBRCSODKHASSW-HEIROHQZSA-N	386781	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-5'-(N- cyclopropylsulfamoyl)- 2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 745::US10822352, Comp No. 745::US11407738, Cmpd No. 521	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386781&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643045	404855923							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190047	CC(=O)Cc1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-15(37)8-21-20-9-17(18-11-30-16(2)31-12-18)6-7-22(20)36(34-21)14-26(38)35-13-19(29)10-23(35)27(39)33-25-5-3-4-24(28)32-25/h3-7,9,11-12,19,23H,8,10,13-14H2,1-2H3,(H,32,33,39)/t19-,23+/m1/s1	ZYLDYDKNCZBDMX-XXBNENTESA-N	563145	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (5-(2- methylpyrimidin-5- yl)-3-(2- oxopropyl)-1H- indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US11407738, Cmpd No. 522	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563145&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624026	472624687							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190048	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(CC(N)=O)c2c1	InChI=1S/C26H24BrFN8O3/c1-14-30-10-16(11-31-14)15-5-6-20-18(7-15)19(9-23(29)37)34-36(20)13-25(38)35-12-17(28)8-21(35)26(39)33-24-4-2-3-22(27)32-24/h2-7,10-11,17,21H,8-9,12-13H2,1H3,(H2,29,37)(H,32,33,39)/t17-,21+/m1/s1	JDUXBLPCGOLKOA-UTKZUKDTSA-N	386407	(2S,4R)-1-(2-(3- (2-amino-2- oxoethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 340::US10822352, Comp No. 340::US11407738, Cmpd No. 523	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386407&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623799	404855563							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190049	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N2CCn3c(C2)nnc3C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25F4N9O3/c1-14(41)24-19-7-16(17-9-32-15(2)33-10-17)3-4-20(19)40(36-24)13-23(42)39-11-18(28)8-21(39)25(43)37-5-6-38-22(12-37)34-35-26(38)27(29,30)31/h3-4,7,9-10,18,21H,5-6,8,11-13H2,1-2H3/t18-,21+/m1/s1	WKZJTIQPJZAWOQ-NQIIRXRSSA-N	563147	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-4- fluoro-2-(3- (trifluoromethyl)- 5,6,7,8-tetrahydro- [1,2,4]triazolo[4,3- a]pyrazine-7- carbonyl)pyrrolidin- 1-yl)ethanone::US11407738, Cmpd No. 524	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563147&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149175	472624689							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190050	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)S(N)(=O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H28ClF2N7O5S/c1-17(44)32-25-10-19(20-13-38-18(2)39-14-20)6-9-28(25)43(41-32)16-30(45)42-15-21(35)11-29(42)33(46)40-27-5-3-4-23(31(27)36)24-12-22(49(37,47)48)7-8-26(24)34/h3-10,12-14,21,29H,11,15-16H2,1-2H3,(H,40,46)(H2,37,47,48)/t21-,29+/m1/s1	GGOIOOYAFPJIFL-PBBNMVCDSA-N	386408	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-2- fluoro-5'- sulfamoyl-[1,1'- biphenyl]-3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 341::US10822352, Comp No. 341::US11407738, Cmpd No. 525	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386408&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642908	404855564							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190051	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(O)Cc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrFN6O3/c1-15(36)27-21-8-17(18-11-30-16(2)31-12-18)6-7-22(21)35(33-27)14-26(38)34-13-19(29)9-23(34)24(37)10-20-4-3-5-25(28)32-20/h3-8,11-12,19,23-24,37H,9-10,13-14H2,1-2H3/t19-,23+,24?/m1/s1	UPYSRAGJDIBMBQ-DHFLCVKNSA-N	563149	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2- ((S)-2-(6- bromopyridin-2- yl)-1- hydroxyethyl)-4- fluoropyrrolidin-2- yl)ethanone::US11407738, Cmpd No. 526::US11407738, Example 00336	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563149&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653777	472624690							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190052	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=S)c2c1	InChI=1S/C25H22BrFN8O2S/c1-13-29-9-15(10-30-13)14-5-6-18-17(7-14)23(24(28)38)33-35(18)12-22(36)34-11-16(27)8-19(34)25(37)32-21-4-2-3-20(26)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,28,38)(H,31,32,37)/t16-,19+/m1/s1	HPNKQDUUICGYMI-APWZRJJASA-N	563150	(2S,4R)-N-(6- bromopyridin-2- yl)-1-(2-(3- carbamothioyl-5- (2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 527	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563150&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623889	472624691							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190053	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccc3OC(F)(F)Oc3c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H26F4N6O5/c1-17(45)32-24-10-19(21-13-39-18(2)40-14-21)6-8-26(24)44(42-32)16-30(46)43-15-22(35)12-27(43)33(47)41-25-5-3-4-23(31(25)36)20-7-9-28-29(11-20)49-34(37,38)48-28/h3-11,13-14,22,27H,12,15-16H2,1-2H3,(H,41,47)/t22-,27+/m1/s1	FHNNXNNPGJGTAH-AMGIVPHBSA-N	563151	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- (2,2-difluoro- benzo[d][1,3]dioxol- 5-yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 528	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563151&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624117	472624692							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190054	CNS(=O)(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1F	InChI=1S/C34H30ClF2N7O5S/c1-18(45)33-26-11-20(21-14-39-19(2)40-15-21)7-10-29(26)44(42-33)17-31(46)43-16-22(36)12-30(43)34(47)41-28-6-4-5-24(32(28)37)25-13-23(8-9-27(25)35)50(48,49)38-3/h4-11,13-15,22,30,38H,12,16-17H2,1-3H3,(H,41,47)/t22-,30+/m1/s1	ZLAJFNIIBSQNMV-RCRUUEGKSA-N	386409	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-2- fluoro-5'-(N- methylsulfamoyl)- [1,1'-biphenyl]- 3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 342::US10822352, Comp No. 342::US11407738, Cmpd No. 529	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386409&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643097	404855565							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190055	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C34H28ClF5N8O3/c1-18(49)31-23-14-20(45-11-12-46-28(16-45)42-43-33(46)34(38,39)40)9-10-26(23)48(44-31)17-29(50)47-15-19(36)13-27(47)32(51)41-25-8-4-6-22(30(25)37)21-5-2-3-7-24(21)35/h2-10,14,19,27H,11-13,15-17H2,1H3,(H,41,51)/t19-,27+/m1/s1	LQPIYWGRJBQSAT-WINIVTDRSA-N	563153	(2S,4R)-1-(2-(3- acetyl-5-(3- (trifluoromethyl)- 5,6-dihydro- [1,2,4]triazolo[4,3- a]pyrazin-7(8H)- yl)-1H-indazol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 531::US11407738, Example 00408	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563153&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149112	472624694							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190056	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(CC2)C(=O)c2cc(Cl)c[nH]2)c2ccc(cc12)-c1cnc(C)nc1			386303	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(1-(4- chloro-1H-pyrrole-2- carbonyl)piperidin- 4-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 232::US11407738, Example 00328	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386303&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642861	404855460							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190057	COCCN(C)CCN1CC(CC1=O)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H39FN8O5/c1-19(41)30-25-11-21(22-14-33-20(2)34-15-22)5-6-26(25)40(36-30)18-29(43)39-16-23(32)12-27(39)31(44)35-24-13-28(42)38(17-24)8-7-37(3)9-10-45-4/h5-6,11,14-15,23-24,27H,7-10,12-13,16-18H2,1-4H3,(H,35,44)/t23-,24?,27+/m1/s1	IXOSDSLTMAYVDU-WRNLUVMSSA-N	386325	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(1-(2-((2- methoxyethyl)(methyl) amino)ethyl)-5- oxopyrrolidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 254::US10822352, Comp No. 254::US11407738, Example 00329	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386325	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386325&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643275	404855482							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190058	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(CC2)C(=O)c2cn[nH]c2)c2ccc(cc12)-c1cnc(C)nc1			386332	(2S,4R)-N-(1-(1H- pyrazole-4- carbonyl)piperidin- 4-yl)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 261::US10822352, Comp No. 261::US11407738, Example 00330	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386332&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643502	404855489							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190059	CC(=O)c1nn(CC(O)=O)c2ccc(cc12)-c1cnc(NCCCCCCCCCC=C)nc1	InChI=1S/C26H33N5O3/c1-3-4-5-6-7-8-9-10-11-14-27-26-28-16-21(17-29-26)20-12-13-23-22(15-20)25(19(2)32)30-31(23)18-24(33)34/h3,12-13,15-17H,1,4-11,14,18H2,2H3,(H,33,34)(H,27,28,29)	KYODOGCTIYMACT-UHFFFAOYSA-N	563157	2-(3-acetyl-5-(2- (undec-10-en-1- ylamino)pyrimidin- 5-yl)-1H-indazol-1- yl)acetic acid::US11407738, Example 00331	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563157&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622873	472624698							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190060	CC(=O)c1nn(CC(=O)NCc2ccccc2CC(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H23N5O4/c1-15(31)25-21-9-18(20-12-26-16(2)27-13-20)7-8-22(21)30(29-25)14-23(32)28-11-19-6-4-3-5-17(19)10-24(33)34/h3-9,12-13H,10-11,14H2,1-2H3,(H,28,32)(H,33,34)	VXNQHUIQSRSNMR-UHFFFAOYSA-N	563158	2-(2-((2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetamido)meth- yl)phenyl)acetic acid::US11407738, Example 00332	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563158&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149122	472624699							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190061	COC(=O)Cc1ccccc1CNC(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C26H25N5O4/c1-16(32)26-22-10-19(21-13-27-17(2)28-14-21)8-9-23(22)31(30-26)15-24(33)29-12-20-7-5-4-6-18(20)11-25(34)35-3/h4-10,13-14H,11-12,15H2,1-3H3,(H,29,33)	CDWKFYBOUZGROU-UHFFFAOYSA-N	563159	US11407738, Example 00333::methyl 2-(2-((2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetamido)meth- yl)phenyl)acetate	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563159&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149119	472624700							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190062	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(F)ccc2S(C)(=O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H29F3N6O5S/c1-18(44)33-26-11-20(21-14-38-19(2)39-15-21)7-9-28(26)43(41-33)17-31(45)42-16-23(36)13-29(42)34(46)40-27-6-4-5-24(32(27)37)25-12-22(35)8-10-30(25)49(3,47)48/h4-12,14-15,23,29H,13,16-17H2,1-3H3,(H,40,46)/t23-,29+/m1/s1	YUNBZWYDNPTXJJ-BTYSJIOQSA-N	386376	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2,5'- difluoro-2'- (methylsulfonyl) biphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 305::US10822352, Comp No. 305::US11407738, Example 00335	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386376&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642967	404855533							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190063	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(O)Cc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrFN6O3/c1-15(36)27-21-8-17(18-11-30-16(2)31-12-18)6-7-22(21)35(33-27)14-26(38)34-13-19(29)9-23(34)24(37)10-20-4-3-5-25(28)32-20/h3-8,11-12,19,23-24,37H,9-10,13-14H2,1-2H3/t19-,23+,24?/m1/s1	UPYSRAGJDIBMBQ-DHFLCVKNSA-N	563149	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2- ((S)-2-(6- bromopyridin-2- yl)-1- hydroxyethyl)-4- fluoropyrrolidin-2- yl)ethanone::US11407738, Cmpd No. 526::US11407738, Example 00336	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563149&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653777	472624690							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190064	CC(=O)c1nn2CC(=O)N3C[C@H](F)C[C@H]3C(=O)NCc3cc(CCCCCCCCCCCNc4ncc(cn4)-c4ccc2c1c4)cc(Cl)c3F	InChI=1S/C38H44ClF2N7O3/c1-24(49)36-30-17-26-12-13-32(30)48(46-36)23-34(50)47-22-29(40)18-33(47)37(51)43-19-27-15-25(16-31(39)35(27)41)11-9-7-5-3-2-4-6-8-10-14-42-38-44-20-28(26)21-45-38/h12-13,15-17,20-21,29,33H,2-11,14,18-19,22-23H2,1H3,(H,43,51)(H,42,44,45)/t29-,33+/m1/s1	RZDBTXRGTPUEFE-CPBHLAHYSA-N	563162	US11407738, Example 00337	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563162&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135178834	472624702							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190065	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)nc(C(N)=N)c2c1	InChI=1S/C32H27ClF2N8O2/c1-17-38-13-19(14-39-17)18-9-10-26-23(11-18)30(31(36)37)41-43(26)16-28(44)42-15-20(34)12-27(42)32(45)40-25-8-4-6-22(29(25)35)21-5-2-3-7-24(21)33/h2-11,13-14,20,27H,12,15-16H2,1H3,(H3,36,37)(H,40,45)/t20-,27+/m1/s1	AKLGCSPTACJFKR-HRFSGMKKSA-N	563163	(2S,4R)-1-(2-(3- carbamimidoyl-5- (2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00338	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563163&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623789	472624703							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190066	CC(=O)c1nn(CC(=O)N2CCC[C@@H](CNC(=O)c3cccc(Br)n3)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H28BrN7O3/c1-17(37)27-22-11-20(21-13-30-18(2)31-14-21)8-9-24(22)36(34-27)16-26(38)35-10-4-5-19(15-35)12-32-28(39)23-6-3-7-25(29)33-23/h3,6-9,11,13-14,19H,4-5,10,12,15-16H2,1-2H3,(H,32,39)/t19-/m0/s1	PKDPHJRDUOBPCS-IBGZPJMESA-N	563164	(S)-N-((1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)piperidin- 3-yl)methyl)-6- bromopicolinamide::US11407738, Example 00339	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563164&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624011	472624704							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190067	COP(=O)(CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1)OC	InChI=1S/C28H28BrFN7O6P/c1-16-31-11-18(12-32-16)17-7-8-21-20(9-17)27(23(38)15-44(41,42-2)43-3)35-37(21)14-26(39)36-13-19(30)10-22(36)28(40)34-25-6-4-5-24(29)33-25/h4-9,11-12,19,22H,10,13-15H2,1-3H3,(H,33,34,40)/t19-,22+/m1/s1	ODQJAXSGLYGHEO-KNQAVFIVSA-N	563165	US11407738, Example 00340::US11407738, Example 00414::dimethyl (2-(1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrimidin-5- yl)-1H-indazol-3- yl)-2- oxoethyl)phos- phonate	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563165&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135178850	472624705							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190068	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(=O)CP(O)(O)=O)c2c1	InChI=1S/C26H24BrFN7O6P/c1-14-29-9-16(10-30-14)15-5-6-19-18(7-15)25(21(36)13-42(39,40)41)33-35(19)12-24(37)34-11-17(28)8-20(34)26(38)32-23-4-2-3-22(27)31-23/h2-7,9-10,17,20H,8,11-13H2,1H3,(H,31,32,38)(H2,39,40,41)/t17-,20+/m1/s1	FXIQIBCDWNAKQU-XLIONFOSSA-N	563166	(2-(1-(2-((2S,4R)- 2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrimidin-5- yl)-1H-indazol-3- yl)-2- oxoethyl)phosphonic acid::US11407738, Example 00341::US11407738, Example 00415	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563166&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149094	472624706							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190069	CC(=O)c1nn(CP(O)(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H24BrFN7O4P/c1-14(35)24-19-8-16(17-10-28-15(2)29-11-17)6-7-20(19)33(32-24)13-39(37,38)34-12-18(27)9-21(34)25(36)31-23-5-3-4-22(26)30-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,37,38)(H,30,31,36)/t18-,21+/m1/s1	BXLZOKHXDQDWRG-NQIIRXRSSA-N	563167	((3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)methyl)((2S,4R)- 2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin-1- yl)phosphinic acid::US11407738, Example 00342::US11407738, Example 00416	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563167&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149098	472624707							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190070	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CN=[N+]=[N-])C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN10O3/c1-15(40)25-19-8-17(18-10-31-16(2)32-11-18)6-7-20(19)39(36-25)12-24(41)38-14-27(29,13-33-37-30)9-21(38)26(42)35-23-5-3-4-22(28)34-23/h3-8,10-11,21H,9,12-14H2,1-2H3,(H,34,35,42)/t21-,27-/m0/s1	XVRDVVNQOYVQDH-IDISGSTGSA-N	563168	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- (azidomethyl)-N- (6-bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00343	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563168&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623249	472624708							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190071	CC(=O)c1nn(CC(=O)N2CCC[C@@H](CNC(=O)c3ncc(Br)s3)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H26BrN7O3S/c1-15(35)24-20-8-18(19-10-28-16(2)29-11-19)5-6-21(20)34(32-24)14-23(36)33-7-3-4-17(13-33)9-30-25(37)26-31-12-22(27)38-26/h5-6,8,10-12,17H,3-4,7,9,13-14H2,1-2H3,(H,30,37)/t17-/m0/s1	GXPQWNQSYSMGOE-KRWDZBQOSA-N	563169	(S)-N-((1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)piperidin- 3-yl)methyl)-5- bromothiazole-2- carboxamide::US11407738, Example 00344	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563169&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623964	472624709							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190072	CC(=O)c1nn(CC(=O)N2C3C[C@@H]3C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C22H21N5O4/c1-11(28)21-16-5-13(15-8-23-12(2)24-9-15)3-4-17(16)26(25-21)10-20(29)27-18-6-14(18)7-19(27)22(30)31/h3-5,8-9,14,18-19H,6-7,10H2,1-2H3,(H,30,31)/t14-,18?,19+/m1/s1	NAWJSZRMUGGVCC-ONZWQQIVSA-N	563170	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-2- azabicyclo[3.1.0]hex- ane-3-carboxylic acid::US11407738, Example 00345::US11407738, Example 00421	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563170&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135179366	472624710							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190073	C[C@@H](O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C21H22FN5O4/c1-11(28)20-16-5-13(14-7-23-12(2)24-8-14)3-4-17(16)27(25-20)10-19(29)26-9-15(22)6-18(26)21(30)31/h3-5,7-8,11,15,18,28H,6,9-10H2,1-2H3,(H,30,31)/t11-,15-,18+/m1/s1	NYLREVJUQISCGE-MZKGEVEHSA-N	563171	(2S,4R)-4-fluoro-1- (2-(3-((R)-1- hydroxyethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxylic acid::US11407738, Example 00346	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563171&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149181	472624711							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190074	C[C@H](O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C21H22FN5O4/c1-11(28)20-16-5-13(14-7-23-12(2)24-8-14)3-4-17(16)27(25-20)10-19(29)26-9-15(22)6-18(26)21(30)31/h3-5,7-8,11,15,18,28H,6,9-10H2,1-2H3,(H,30,31)/t11-,15+,18-/m0/s1	NYLREVJUQISCGE-POHZPAGDSA-N	563172	(2S,4R)-4-fluoro-1- (2-(3-((S)-1- hydroxyethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxylic acid::US11407738, Example 00347	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563172&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149108	472624712							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190075	COC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C22H24FN5O4/c1-12(29)21-17-6-14(15-8-24-13(2)25-9-15)4-5-18(17)28(26-21)11-20(30)27-10-16(23)7-19(27)22(31)32-3/h4-6,8-9,12,16,19,29H,7,10-11H2,1-3H3/t12?,16-,19+/m1/s1	QTYZRLMSHOQDBV-HDPDCCELSA-N	563173	(2S,4R)-methyl 4- fluoro-1-(2-(3-(1- hydroxyethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxylate::US11407738, Example 00348::US11407738, Example 00422	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563173&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149089	472624713							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190076	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H24BrFN8O3/c1-13-3-6-21(27)32-24(13)33-25(39)20-8-17(28)11-35(20)22(38)12-36-19-5-4-15(16-9-30-26(29)31-10-16)7-18(19)23(34-36)14(2)37/h3-7,9-10,17,20H,8,11-12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t17-,20+/m1/s1	XCWPZWHOWUREMG-XLIONFOSSA-N	386499	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 435::US10822352, Comp No. 435::US11407738, Example 00349	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386499&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642917	404855650							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190077	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C27H25BrFN7O4/c1-14-4-7-22(28)32-25(14)33-26(39)21-9-18(29)12-35(21)23(38)13-36-20-6-5-16(8-19(20)24(34-36)15(2)37)17-10-30-27(40-3)31-11-17/h4-8,10-11,18,21H,9,12-13H2,1-3H3,(H,32,33,39)/t18-,21+/m1/s1	BCQLWVGATJBOOL-NQIIRXRSSA-N	386500	(2S,4R)-1-(2-(3- acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 436::US11407738, Example 00350	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386500&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642892	404855651							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190078	C\C(=N/O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN8O3/c1-14(34-39)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)36(33-25)13-24(37)35-12-18(28)9-21(35)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21,39H,9,12-13H2,1-2H3,(H,31,32,38)/b34-14+/t18-,21+/m1/s1	JWDHNPPHXYNBGN-XAFBMYNGSA-N	563176	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-((E)-1- (hydroxyimino)eth- yl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US11407738, Example 00351	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563176&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137128362	472624716							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190079	CC(=O)c1nn(CC(=O)N2CCC[C@H](CNC(=O)c3cccc(Br)n3)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H28BrN7O3/c1-17(37)27-22-11-20(21-13-30-18(2)31-14-21)8-9-24(22)36(34-27)16-26(38)35-10-4-5-19(15-35)12-32-28(39)23-6-3-7-25(29)33-23/h3,6-9,11,13-14,19H,4-5,10,12,15-16H2,1-2H3,(H,32,39)/t19-/m1/s1	PKDPHJRDUOBPCS-LJQANCHMSA-N	563177	(R)-N-((1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)piperidin- 3-yl)methyl)-6- bromopicolinamide::US11407738, Example 00352	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563177&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623809	472624717							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190080	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCOC(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C24H24F4N6O4/c1-13(35)22-18-7-15(16-9-30-14(2)31-10-16)3-4-19(18)34(32-22)12-21(36)33-11-17(25)8-20(33)23(37)29-5-6-38-24(26,27)28/h3-4,7,9-10,17,20H,5-6,8,11-12H2,1-2H3,(H,29,37)/t17-,20+/m1/s1	NJSDTKQTGHLTNP-XLIONFOSSA-N	563178	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(2- (trifluoromethoxy)eth- yl)pyrrolidine-2- carboxamide::US11407738, Example 00353	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563178&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623943	472624718							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190081	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCC(C)(C)C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H33FN6O3/c1-16(35)25-21-10-18(19-12-30-17(2)31-13-19)6-7-22(21)34(32-25)15-24(36)33-14-20(28)11-23(33)26(37)29-9-8-27(3,4)5/h6-7,10,12-13,20,23H,8-9,11,14-15H2,1-5H3,(H,29,37)/t20-,23+/m1/s1	WUHQAYHLBNJMHL-OFNKIYASSA-N	563179	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3,3- dimethylbutyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00354	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563179&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624021	472624719							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190082	Cc1cccc(CC(O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C28H29FN6O3/c1-16-4-3-5-21(33-16)10-26(36)25-9-20(29)13-35(25)27(37)15-34-14-23(28(30)38)22-8-18(6-7-24(22)34)19-11-31-17(2)32-12-19/h3-8,11-12,14,20,25-26,36H,9-10,13,15H2,1-2H3,(H2,30,38)/t20-,25+,26?/m1/s1	HIHOXRKIJLLENT-ACIRKUTISA-N	386518	1-(2-((2S,4R)-4- fluoro-2-((S)-1- hydroxy-2-(6- methylpyridin-2- yl)ethyl)pyrrolidin- 1-yl)-2- oxoethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indole- 3-carboxamide::US10287301, Compound 455::US11407738, Example 00355	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386518&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654075	404855669							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190083	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccc3NCCNc3c2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H31ClF2N8O3/c1-18(47)33-25-12-20(21-14-41-19(2)42-15-21)6-9-28(25)46(44-33)17-30(48)45-16-22(37)13-29(45)35(49)43-26-5-3-4-24(32(26)38)23-7-8-27-34(31(23)36)40-11-10-39-27/h3-9,12,14-15,22,29,39-40H,10-11,13,16-17H2,1-2H3,(H,43,49)/t22-,29+/m1/s1	QEDYAHWSTWVLMN-MNNSJKJDSA-N	563181	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3-(5- chloro-1,2,3,4- tetrahydroquinoxalin- 6-yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00356	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563181&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623823	472624721							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190084	Cc1cccc(CC(O)[C@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C28H29FN6O3/c1-16-4-3-5-21(33-16)10-26(36)25-9-20(29)13-35(25)27(37)15-34-14-23(28(30)38)22-8-18(6-7-24(22)34)19-11-31-17(2)32-12-19/h3-8,11-12,14,20,25-26,36H,9-10,13,15H2,1-2H3,(H2,30,38)/t20-,25-,26?/m1/s1	HIHOXRKIJLLENT-GVHCYZNWSA-N	563182	1-(2-((2R,4R)-4- fluoro-2-((R)-1- hydroxy-2-(6- methylpyridin-2- yl)ethyl)pyrrolidin- 1-yl)-2-oxoethyl)- 5-(2- methylpyrimidin-5- yl)-1H-indole-3- carboxamide::US11407738, Example 00357	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563182&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149110	472624722							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190085	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CNC(=O)c2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25ClF2N6O3/c1-15(38)27-22-8-17(18-10-32-16(2)33-11-18)6-7-24(22)37(35-27)14-25(39)36-13-19(30)9-20(36)12-34-28(40)21-4-3-5-23(29)26(21)31/h3-8,10-11,19-20H,9,12-14H2,1-2H3,(H,34,40)/t19-,20+/m1/s1	SFWSXQQCARYZRT-UXHICEINSA-N	563183	N-(((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)methyl)-3- chloro-2- fluorobenzamide::US11407738, Example 00358	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563183&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149123	472624723							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190086	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CNS(=O)(=O)c2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25ClF2N6O4S/c1-15(37)27-21-8-17(18-10-31-16(2)32-11-18)6-7-23(21)36(34-27)14-25(38)35-13-19(29)9-20(35)12-33-41(39,40)24-5-3-4-22(28)26(24)30/h3-8,10-11,19-20,33H,9,12-14H2,1-2H3/t19-,20+/m1/s1	KLUFLRRNMJZLBX-UXHICEINSA-N	563184	N-(((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)methyl)-3- chloro-2- fluorobenzene- sulfonamide::US11407738, Example 00359	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563184&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149121	472624724							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190087	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2c2nc3nc(Br)ccc3[nH]2)c2ccc(cc12)-c1cnc(C)nc1			563185	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2-(5- bromo-1H- imidazo[4,5- b]pyridin-2-yl)-4- fluoropyrrolidin-1- yl)ethan-1-one::US11407738, Example 00360	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563185&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624002	472624725							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190088	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@@H]2c2nc3nc(Br)ccc3[nH]2)c2ccc(cc12)-c1cnc(C)nc1			563186	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2R,4R)-2- (5-bromo-1H- imidazo[4,5- b]pyridin-2-yl)-4- fluoropyrrolidin-1- yl)ethan-1-one::US11407738, Example 00361	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563186&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623995	472624726							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190089	Cc1cccc(NC(=O)[C@@H]2CC=CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C28H27N7O3/c1-17-6-5-8-25(32-17)33-28(38)24-7-3-4-11-35(24)26(36)16-34-15-22(27(29)37)21-12-19(9-10-23(21)34)20-13-30-18(2)31-14-20/h3-6,8-10,12-15,24H,7,11,16H2,1-2H3,(H2,29,37)(H,32,33,38)/t24-/m0/s1	OPNOYUMKDDPPDW-DEOSSOPVSA-N	563187	(S)-1-(2-(6-((6- methylpyridin-2- yl)carbamoyl)-5,6- dihydropyridin- 1(2H)-yl)-2- oxoethyl)-5-(2- methylpyrimidin-5- yl)-1H-indole-3- carboxamide::US11407738, Example 00362	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563187&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624057	472624727							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190090	CC(=O)c1nn(CC(=O)N2CC=CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27N7O3/c1-17-7-6-9-25(31-17)32-28(38)24-8-4-5-12-34(24)26(37)16-35-23-11-10-20(21-14-29-19(3)30-15-21)13-22(23)27(33-35)18(2)36/h4-7,9-11,13-15,24H,8,12,16H2,1-3H3,(H,31,32,38)/t24-/m0/s1	GJIANMLWECSOHB-DEOSSOPVSA-N	563188	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)-1,2,3,6- tetrahydropyridine- 2-carboxamide::US11407738, Example 00363	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563188&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624043	472624728							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190091	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)OCc2ccc(Br)nc2N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O4/c1-14(37)25-20-7-16(18-9-31-15(2)32-10-18)3-5-21(20)36(34-25)12-24(38)35-11-19(29)8-22(35)27(39)40-13-17-4-6-23(28)33-26(17)30/h3-7,9-10,19,22H,8,11-13H2,1-2H3,(H2,30,33)/t19-,22+/m1/s1	QVZDXIPOSBBKLM-KNQAVFIVSA-N	563189	(2S,4R)-(2-amino- 6-bromopyridin-3- yl)methyl 1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxylate::US11407738, Example 00364	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563189&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149128	472624729							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190092	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2c2nnc([nH]2)-c2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1			563190	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2-(5- (3-chloro-2- fluorophenyl)-4H- 1,2,4-triazol-3-yl)- 4-fluoropyrrolidin- 1-yl)ethan-1-one::US11407738, Example 00365	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563190&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623830	472624730							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190093	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@@H]2c2nnc([nH]2)-c2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1			563191	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2R,4R)-2- (5-(3-chloro-2- fluorophenyl)-4H- 1,2,4-triazol-3-yl)- 4-fluoropyrrolidin- 1-yl)ethan-1-one::US11407738, Example 00366	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563191&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623985	472624731							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190094	CC(=O)c1nn(CC(=O)N2CC=CC[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-16(36)26-20-12-18(19-13-29-17(2)30-14-19)9-10-21(20)35(33-26)15-25(37)34-11-4-3-6-22(34)27(38)32-24-8-5-7-23(28)31-24/h3-5,7-10,12-14,22H,6,11,15H2,1-2H3,(H,31,32,38)/t22-/m0/s1	IUHOQDDGAIIJMG-QFIPXVFZSA-N	563192	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-1,2,3,6- tetrahydropyridine- 2-carboxamide::US11407738, Example 00367	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563192&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624036	472624732							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190095	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2c2nnc(o2)-c2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H22ClF2N7O3/c1-14(39)26-20-8-16(17-10-32-15(2)33-11-17)6-7-22(20)38(36-26)13-24(40)37-12-18(30)9-23(37)28-35-34-27(41-28)19-4-3-5-21(29)25(19)31/h3-8,10-11,18,23H,9,12-13H2,1-2H3/t18-,23+/m1/s1	VQDGRAKKRWWCDO-JPYJTQIMSA-N	563193	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2-(5- (3-chloro-2- fluorophenyl)- 1,3,4-oxadiazol-2- yl)-4- fluoropyrrolidin-1- yl)ethan-1-one::US11407738, Example 00368	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563193&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623913	472624733							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190096	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CC(N)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C22H23FN6O3/c1-12(30)22-18-5-14(15-8-25-13(2)26-9-15)3-4-19(18)29(27-22)11-21(32)28-10-16(23)6-17(28)7-20(24)31/h3-5,8-9,16-17H,6-7,10-11H2,1-2H3,(H2,24,31)/t16-,17+/m1/s1	GAWXMZGUBOVJCE-SJORKVTESA-N	563194	2-((2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)acetamide::US11407738, Example 00369	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563194&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624147	472624734							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190097	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CC(=O)Nc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25ClF2N6O3/c1-15(38)28-21-8-17(18-11-32-16(2)33-12-18)6-7-24(21)37(35-28)14-26(40)36-13-19(30)9-20(36)10-25(39)34-23-5-3-4-22(29)27(23)31/h3-8,11-12,19-20H,9-10,13-14H2,1-2H3,(H,34,39)/t19-,20+/m1/s1	QWBHCISGYDCLEX-UXHICEINSA-N	563195	2-((2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)-N-(3-chloro-2- fluorophenyl)aceta- mide::US11407738, Example 00370	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563195&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624145	472624735							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190098	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CC(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C22H22FN5O4/c1-12(29)22-18-5-14(15-8-24-13(2)25-9-15)3-4-19(18)28(26-22)11-20(30)27-10-16(23)6-17(27)7-21(31)32/h3-5,8-9,16-17H,6-7,10-11H2,1-2H3,(H,31,32)/t16-,17+/m1/s1	VTYSFNYSWTVCHL-SJORKVTESA-N	563196	2-((2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)acetic acid::US11407738, Example 00371	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563196&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624143	472624736							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190099	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C29H30FN7O3/c1-17-4-3-5-26(34-17)35-29(40)25-9-7-21(30)10-11-37(25)27(38)16-36-15-23(28(31)39)22-12-19(6-8-24(22)36)20-13-32-18(2)33-14-20/h3-6,8,12-15,21,25H,7,9-11,16H2,1-2H3,(H2,31,39)(H,34,35,40)/t21?,25-/m0/s1	VXZGPPZMGNDNLU-QBGQUKIHSA-N	563197	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5-(2- methylpyrimidin-5- yl)-1H-indole-3- carboxamide::US11407738, Example 00372	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563197&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623907	472624737							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190100	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CC(=O)NC#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C23H22FN7O3/c1-13(32)23-19-5-15(16-8-26-14(2)27-9-16)3-4-20(19)31(29-23)11-22(34)30-10-17(24)6-18(30)7-21(33)28-12-25/h3-5,8-9,17-18H,6-7,10-11H2,1-2H3,(H,28,33)/t17-,18+/m1/s1	REVPMUYXWSSVIE-MSOLQXFVSA-N	563198	2-((2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)-N- cyanoacetamide::US11407738, Example 00373	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563198&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623855	472624738							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190101	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CC(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-15(37)27-21-8-17(18-11-30-16(2)31-12-18)6-7-22(21)36(34-27)14-26(39)35-13-19(29)9-20(35)10-25(38)33-24-5-3-4-23(28)32-24/h3-8,11-12,19-20H,9-10,13-14H2,1-2H3,(H,32,33,38)/t19-,20+/m1/s1	XCSPDTIGAMCEKV-UXHICEINSA-N	563199	2-((2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)-N-(6- bromopyridin-2- yl)acetamide::US11407738, Example 00374	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563199&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624039	472624739							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190102	CCOP(=O)(OCC)OC[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN7O7P/c1-5-45-48(44,46-6-2)47-18-32-13-25(31(43)37-28-9-7-8-27(33)36-28)40(26(32)14-32)29(42)17-39-24-11-10-21(22-15-34-20(4)35-16-22)12-23(24)30(38-39)19(3)41/h7-12,15-16,25-26H,5-6,13-14,17-18H2,1-4H3,(H,36,37,43)/t25-,26-,32+/m0/s1	AJSNKKKHCUFVIG-RCXVBCEZSA-N	563200	((1S,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-((6- bromopyridin-2- yl)carbamoyl)-2- azabicyclo[3.1.0]hex- an-5-yl)methyl diethyl phosphate::US11407738, Example 00375::US11407738, Example 00417	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563200&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623745	472624740							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190103	CCOP(=O)(OCC)OC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN7O7P/c1-5-45-48(44,46-6-2)47-18-32-13-25(31(43)37-28-9-7-8-27(33)36-28)40(26(32)14-32)29(42)17-39-24-11-10-21(22-15-34-20(4)35-16-22)12-23(24)30(38-39)19(3)41/h7-12,15-16,25-26H,5-6,13-14,17-18H2,1-4H3,(H,36,37,43)/t25-,26+,32-/m0/s1	AJSNKKKHCUFVIG-BKQYKDOASA-N	563201	((1R,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-((6- bromopyridin-2- yl)carbamoyl)-2- azabicyclo[3.1.0]hex- an-5-yl)methyl diethyl phosphate::US11407738, Example 00376::US11407738, Example 00418	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563201&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623952	472624741							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190104	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2c2nnc(CCCC(F)(F)F)o2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25F4N7O3/c1-14(38)24-19-8-16(17-10-31-15(2)32-11-17)5-6-20(19)37(35-24)13-23(39)36-12-18(27)9-21(36)25-34-33-22(40-25)4-3-7-26(28,29)30/h5-6,8,10-11,18,21H,3-4,7,9,12-13H2,1-2H3/t18-,21+/m1/s1	QOJQWGLLDWTYPT-NQIIRXRSSA-N	563202	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-4- fluoro-2-(5-(4,4,4- trifluorobutyl)- 1,3,4-oxadiazol-2- yl)pyrrolidin-1- yl)ethan-1-one::US11407738, Example 00377	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563202&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623818	472624742							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190105	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2c2nnc(CCCC(F)(F)F)[nH]2)c2ccc(cc12)-c1cnc(C)nc1			563203	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-4- fluoro-2-(5-(4,4,4- trifluorobutyl)-4H- 1,2,4-triazol-3- yl)pyrrolidin-1- yl)ethan-1-one::US11407738, Example 00378	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563203&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623871	472624743							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190106	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(=O)NS(C)(=O)=O)c2c1	InChI=1S/C26H24BrFN8O5S/c1-14-29-10-16(11-30-14)15-6-7-19-18(8-15)24(26(39)34-42(2,40)41)33-36(19)13-23(37)35-12-17(28)9-20(35)25(38)32-22-5-3-4-21(27)31-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,34,39)(H,31,32,38)/t17-,20+/m1/s1	PYTDUFQOUHRLHX-XLIONFOSSA-N	563204	1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrimidin-5- yl)-N- (methylsulfonyl)- 1H-indazole-3- carboxamide::US11407738, Example 00379	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563204&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623953	472624744							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190107	Cc1ccc(cn1)-c1ccc2n(CC(=O)N3CCC(F)CC[C@H]3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H31FN6O3/c1-18-6-7-21(15-33-18)20-8-10-25-23(14-20)24(29(32)39)16-36(25)17-28(38)37-13-12-22(31)9-11-26(37)30(40)35-27-5-3-4-19(2)34-27/h3-8,10,14-16,22,26H,9,11-13,17H2,1-2H3,(H2,32,39)(H,34,35,40)/t22?,26-/m0/s1	QQDBRUCVFJCITG-XGCAABAXSA-N	563205	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5-(6- methylpyridin-3- yl)-1H-indole-3- carboxamide::US11407738, Example 00380	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563205&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623979	472624745							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190108	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3CCc3c2)n1	InChI=1S/C32H32FN5O3/c1-19-3-2-4-29(35-19)36-32(41)28-12-10-24(33)13-14-38(28)30(39)18-37-17-26(31(34)40)25-16-23(9-11-27(25)37)22-8-6-20-5-7-21(20)15-22/h2-4,6,8-9,11,15-17,24,28H,5,7,10,12-14,18H2,1H3,(H2,34,40)(H,35,36,41)/t24?,28-/m0/s1	RAGOZTHTKVIINA-AZKKKJBWSA-N	563206	5- (bicyclo[4.2.0]octa- 1(6),2,4-trien-3-yl)- 1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US11407738, Example 00381	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563206&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624040	472624746							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190109	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cccnc2)n1	InChI=1S/C29H29FN6O3/c1-18-4-2-6-26(33-18)34-29(39)25-10-8-21(30)11-13-36(25)27(37)17-35-16-23(28(31)38)22-14-19(7-9-24(22)35)20-5-3-12-32-15-20/h2-7,9,12,14-16,21,25H,8,10-11,13,17H2,1H3,(H2,31,38)(H,33,34,39)/t21?,25-/m0/s1	ZQNXPFIFIZJTSA-QBGQUKIHSA-N	563207	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5- (pyridin-3-yl)-1H- indole-3- carboxamide::US11407738, Example 00382	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563207&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623795	472624747							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190110	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3CCCCc3c2)n1	InChI=1S/C34H36FN5O3/c1-21-5-4-8-31(37-21)38-34(43)30-14-12-26(35)15-16-40(30)32(41)20-39-19-28(33(36)42)27-18-25(11-13-29(27)39)24-10-9-22-6-2-3-7-23(22)17-24/h4-5,8-11,13,17-19,26,30H,2-3,6-7,12,14-16,20H2,1H3,(H2,36,42)(H,37,38,43)/t26?,30-/m0/s1	BGEKZVOMBZYLTQ-WSXWNZDHSA-N	563208	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5- (5,6,7,8- tetrahydronaphthalen- 2-yl)-1H-indole- 3-carboxamide::US11407738, Example 00383	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563208&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623750	472624748							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190111	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc(F)nc2)n1	InChI=1S/C29H28F2N6O3/c1-17-3-2-4-26(34-17)35-29(40)24-9-7-20(30)11-12-37(24)27(38)16-36-15-22(28(32)39)21-13-18(5-8-23(21)36)19-6-10-25(31)33-14-19/h2-6,8,10,13-15,20,24H,7,9,11-12,16H2,1H3,(H2,32,39)(H,34,35,40)/t20?,24-/m0/s1	KAJGUMJTSLEEDN-JWIMYKKASA-N	563209	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5-(6- fluoropyridin-3-yl)- 1H-indole-3- carboxamide::US11407738, Example 00384	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563209&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623928	472624749							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190112	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cccc(c2)C#N)n1	InChI=1S/C31H29FN6O3/c1-19-4-2-7-28(35-19)36-31(41)27-11-9-23(32)12-13-38(27)29(39)18-37-17-25(30(34)40)24-15-22(8-10-26(24)37)21-6-3-5-20(14-21)16-33/h2-8,10,14-15,17,23,27H,9,11-13,18H2,1H3,(H2,34,40)(H,35,36,41)/t23?,27-/m0/s1	ATWYSXSLJZBTND-JVHFYALYSA-N	563210	5-(3-cyanophenyl)- 1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US11407738, Example 00385	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563210&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623831	472624750							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190113	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CC(=O)NO)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C22H23FN6O4/c1-12(30)22-18-5-14(15-8-24-13(2)25-9-15)3-4-19(18)29(26-22)11-21(32)28-10-16(23)6-17(28)7-20(31)27-33/h3-5,8-9,16-17,33H,6-7,10-11H2,1-2H3,(H,27,31)/t16-,17+/m1/s1	SMBDQZVMNJEZJR-SJORKVTESA-N	563211	2-((2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)-N- hydroxyacetamide::US11407738, Example 00386	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563211&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624038	472624751							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190114	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc3CCCc3c2)n1	InChI=1S/C32H33FN6O3/c1-19-4-2-7-29(36-19)37-32(42)28-11-9-23(33)12-13-39(28)30(40)18-38-17-25(31(34)41)24-15-20(8-10-27(24)38)22-14-21-5-3-6-26(21)35-16-22/h2,4,7-8,10,14-17,23,28H,3,5-6,9,11-13,18H2,1H3,(H2,34,41)(H,36,37,42)/t23?,28-/m0/s1	PARVEXNULQVXIQ-WOKNPCPGSA-N	563212	5-(6,7-dihydro-5H- cyclopenta[b]pyridin- 3-yl)-1-(2-((2S)- 5-fluoro-2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US11407738, Example 00387	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563212&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623862	472624752							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190115	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3ccccc3c2)n1	InChI=1S/C34H32FN5O3/c1-21-5-4-8-31(37-21)38-34(43)30-14-12-26(35)15-16-40(30)32(41)20-39-19-28(33(36)42)27-18-25(11-13-29(27)39)24-10-9-22-6-2-3-7-23(22)17-24/h2-11,13,17-19,26,30H,12,14-16,20H2,1H3,(H2,36,42)(H,37,38,43)/t26?,30-/m0/s1	CRIHVHKRHBDFMM-WSXWNZDHSA-N	563213	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5- (naphthalen-2-yl)- 1H-indole-3- carboxamide::US11407738, Example 00388	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563213&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623868	472624753							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190116	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc(N)nc2)n1	InChI=1S/C29H30FN7O3/c1-17-3-2-4-26(34-17)35-29(40)24-9-7-20(30)11-12-37(24)27(38)16-36-15-22(28(32)39)21-13-18(5-8-23(21)36)19-6-10-25(31)33-14-19/h2-6,8,10,13-15,20,24H,7,9,11-12,16H2,1H3,(H2,31,33)(H2,32,39)(H,34,35,40)/t20?,24-/m0/s1	ULARUCDVMPQQCY-JWIMYKKASA-N	563214	5-(6-aminopyridin- 3-yl)-1-(2-((2S)-5- fluoro-2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US11407738, Example 00389	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563214&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623941	472624754							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190117	COc1ccc(cn1)-c1ccc2n(CC(=O)N3CCC(F)CC[C@H]3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H31FN6O4/c1-18-4-3-5-26(34-18)35-30(40)25-10-8-21(31)12-13-37(25)28(38)17-36-16-23(29(32)39)22-14-19(6-9-24(22)36)20-7-11-27(41-2)33-15-20/h3-7,9,11,14-16,21,25H,8,10,12-13,17H2,1-2H3,(H2,32,39)(H,34,35,40)/t21?,25-/m0/s1	JQDCSPCHTFKMOZ-QBGQUKIHSA-N	563215	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5-(6- methoxypyridin-3- yl)-1H-indole-3- carboxamide::US11407738, Example 00390	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563215&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624045	472624755							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190118	CC[C@@H](N(C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C26H26BrN7O3/c1-5-20(26(37)31-23-8-6-7-22(27)30-23)33(4)24(36)14-34-21-10-9-17(18-12-28-16(3)29-13-18)11-19(21)25(32-34)15(2)35/h6-13,20H,5,14H2,1-4H3,(H,30,31,37)/t20-/m1/s1	QSUQPMVIDWWCHY-HXUWFJFHSA-N	563216	(R)-2-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-N- methylacetamido)- N-(6-bromopyridin- 2-yl)butanamide::US11407738, Example 00391	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563216&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623827	472624756							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190119	CC[C@H](N(C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C26H26BrN7O3/c1-5-20(26(37)31-23-8-6-7-22(27)30-23)33(4)24(36)14-34-21-10-9-17(18-12-28-16(3)29-13-18)11-19(21)25(32-34)15(2)35/h6-13,20H,5,14H2,1-4H3,(H,30,31,37)/t20-/m0/s1	QSUQPMVIDWWCHY-FQEVSTJZSA-N	563217	(S)-2-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-N- methylacetamido)- N-(6-bromopyridin- 2-yl)butanamide::US11407738, Example 00392	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563217&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623717	472624757							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190120	CC[C@@H](NC(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C25H24BrN7O3/c1-4-19(25(36)31-22-7-5-6-21(26)30-22)29-23(35)13-33-20-9-8-16(17-11-27-15(3)28-12-17)10-18(20)24(32-33)14(2)34/h5-12,19H,4,13H2,1-3H3,(H,29,35)(H,30,31,36)/t19-/m1/s1	NKUXJBUHBSIOFB-LJQANCHMSA-N	563218	(R)-2-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetamido)-N- (6-bromopyridin-2- yl)butanamide::US11407738, Example 00393	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563218&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623856	472624758							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190121	CC[C@H](NC(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C25H24BrN7O3/c1-4-19(25(36)31-22-7-5-6-21(26)30-22)29-23(35)13-33-20-9-8-16(17-11-27-15(3)28-12-17)10-18(20)24(32-33)14(2)34/h5-12,19H,4,13H2,1-3H3,(H,29,35)(H,30,31,36)/t19-/m0/s1	NKUXJBUHBSIOFB-IBGZPJMESA-N	563219	(S)-2-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetamido)-N- (6-bromopyridin-2- yl)butanamide::US11407738, Example 00394	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563219&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623766	472624759							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190122	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCC#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C23H22FN7O3/c1-13(32)22-18-7-15(16-9-27-14(2)28-10-16)3-4-19(18)31(29-22)12-21(33)30-11-17(24)8-20(30)23(34)26-6-5-25/h3-4,7,9-10,17,20H,6,8,11-12H2,1-2H3,(H,26,34)/t17-,20+/m1/s1	JYJQJRBGLAPNPD-XLIONFOSSA-N	563220	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N- (cyanomethyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00395	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563220&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149203	472624760							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190123	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3cccnc3c2)n1	InChI=1S/C33H31FN6O3/c1-20-4-2-6-30(37-20)38-33(43)29-12-10-24(34)13-15-40(29)31(41)19-39-18-26(32(35)42)25-16-22(9-11-28(25)39)23-8-7-21-5-3-14-36-27(21)17-23/h2-9,11,14,16-18,24,29H,10,12-13,15,19H2,1H3,(H2,35,42)(H,37,38,43)/t24?,29-/m0/s1	HFCWLDYGXUBELP-PEFOLFAWSA-N	563221	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5- (quinolin-7-yl)-1H- indole-3- carboxamide::US11407738, Example 00396	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563221&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624047	472624761							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190124	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CS(=O)(=O)c2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN6O4S/c1-15(35)26-21-8-17(18-10-29-16(2)30-11-18)6-7-22(21)34(32-26)13-25(36)33-12-19(28)9-20(33)14-39(37,38)24-5-3-4-23(27)31-24/h3-8,10-11,19-20H,9,12-14H2,1-2H3/t19-,20+/m1/s1	HGAPQXSMGLJRDG-UXHICEINSA-N	563222	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2- (((6-bromopyridin- 2- yl)sulfonyl)methyl)- 4-fluoropyrrolidin- 1-yl)ethan-1-one::US11407738, Example 00397	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563222&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623949	472624762							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190125	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CS(=O)c2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN6O3S/c1-15(35)26-21-8-17(18-10-29-16(2)30-11-18)6-7-22(21)34(32-26)13-25(36)33-12-19(28)9-20(33)14-38(37)24-5-3-4-23(27)31-24/h3-8,10-11,19-20H,9,12-14H2,1-2H3/t19-,20+,38?/m1/s1	WZSFRPMHLDZGBF-ZVRXFCSUSA-N	563223	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2- (((6-bromopyridin- 2- yl)sulfinyl)methyl)- 4-fluoropyrrolidin- 1-yl)ethan-1-one::US11407738, Example 00398	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563223&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623963	472624763							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190126	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25F3N8O3/c1-14(39)24-20-7-16(18-9-31-15(2)32-10-18)3-4-21(20)38(35-24)12-23(40)37-11-17-8-19(17)25(37)26(41)33-22-5-6-36(34-22)13-27(28,29)30/h3-7,9-10,17,19,25H,8,11-13H2,1-2H3,(H,33,34,41)/t17-,19-,25+/m1/s1	UNQZSLWAOMKHKP-IZJXBPLLSA-N	386689	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3-yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 638::US10822352, Comp No. 638::US11407738, Example 00399	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386689&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642790	404855837							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190127	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@@H]3C(O)Cc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H30FN7O3/c1-17-4-3-5-22(34-17)11-27(39)26-10-21(31)14-37(26)29(40)16-36-15-24(30(32)41)23-9-19(6-7-25(23)36)20-12-33-28-8-18(2)35-38(28)13-20/h3-9,12-13,15,21,26-27,39H,10-11,14,16H2,1-2H3,(H2,32,41)/t21-,26-,27?/m1/s1	YJKHVVOFYPQPDA-XEEHWLSFSA-N	563225	1-(2-((2R,4R)-4- fluoro-2-((R)-1- hydroxy-2-(6- methylpyridin-2- yl)ethyl)pyrrolidin- 1-yl)-2-oxoethyl)- 5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indole-3- carboxamide::US11407738, Example 00400	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563225&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149107	472624765							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190128	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3CC=CC[C@H]3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H28N8O3/c1-18-6-5-8-26(33-18)34-30(41)25-7-3-4-11-37(25)28(39)17-36-16-23(29(31)40)22-13-20(9-10-24(22)36)21-14-32-27-12-19(2)35-38(27)15-21/h3-6,8-10,12-16,25H,7,11,17H2,1-2H3,(H2,31,40)(H,33,34,41)/t25-/m0/s1	GMUHBURNVAWGQO-VWLOTQADSA-N	563226	(S)-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1-(2-(6-((6- methylpyridin-2- yl)carbamoyl)-5,6- dihydropyridin- 1(2H)-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US11407738, Example 00401	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563226&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623800	472624766							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190129	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(O)Cc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H30FN7O3/c1-17-4-3-5-22(34-17)11-27(39)26-10-21(31)14-37(26)29(40)16-36-15-24(30(32)41)23-9-19(6-7-25(23)36)20-12-33-28-8-18(2)35-38(28)13-20/h3-9,12-13,15,21,26-27,39H,10-11,14,16H2,1-2H3,(H2,32,41)/t21-,26+,27?/m1/s1	YJKHVVOFYPQPDA-AWDXVTQCSA-N	563227	1-(2-((2S,4R)-4- fluoro-2-((S)-1- hydroxy-2-(6- methylpyridin-2- yl)ethyl)pyrrolidin- 1-yl)-2-oxoethyl)- 5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indole-3- carboxamide::US11407738, Example 00402	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563227&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135178958	472624767							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190130	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3CCC(F)CC[C@H]3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C31H31FN8O3/c1-18-4-3-5-27(35-18)36-31(43)26-9-7-22(32)10-11-39(26)29(41)17-38-16-24(30(33)42)23-13-20(6-8-25(23)38)21-14-34-28-12-19(2)37-40(28)15-21/h3-6,8,12-16,22,26H,7,9-11,17H2,1-2H3,(H2,33,42)(H,35,36,43)/t22?,26-/m0/s1	RQSDKCMYLUSLOQ-XGCAABAXSA-N	563228	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indole-3- carboxamide::US11407738, Example 00403	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563228&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623958	472624768							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190131	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc3ccccn23)n1	InChI=1S/C31H30FN7O3/c1-19-5-4-6-27(35-19)36-31(42)25-11-9-21(32)12-14-39(25)29(40)18-37-17-23(30(33)41)22-15-20(8-10-24(22)37)26-16-34-28-7-2-3-13-38(26)28/h2-8,10,13,15-17,21,25H,9,11-12,14,18H2,1H3,(H2,33,41)(H,35,36,42)/t21?,25-/m0/s1	XZVQXKVLMYCTTM-QBGQUKIHSA-N	563229	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5- (imidazo[1,2- a]pyridin-3-yl)-1H- indole-3- carboxamide::US11407738, Example 00404	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563229&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149136	472624769							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190132	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc3CCCCn23)n1	InChI=1S/C31H34FN7O3/c1-19-5-4-6-27(35-19)36-31(42)25-11-9-21(32)12-14-39(25)29(40)18-37-17-23(30(33)41)22-15-20(8-10-24(22)37)26-16-34-28-7-2-3-13-38(26)28/h4-6,8,10,15-17,21,25H,2-3,7,9,11-14,18H2,1H3,(H2,33,41)(H,35,36,42)/t21?,25-/m0/s1	FIGVGMCQZHHQOY-QBGQUKIHSA-N	563230	1-(2-((2S)-5-fluoro- 2-((6- methylpyridin-2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-5- (5,6,7,8- tetrahydroimidazo [1,2-a]pyridin-3-yl)- 1H-indole-3- carboxamide::US11407738, Example 00405	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563230&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623836	472624770							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190133	Cc1cccc(NC(=O)[C@@H]2CCC(F)CCN2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnn3CCCc23)n1	InChI=1S/C30H32FN7O3/c1-18-4-2-6-27(34-18)35-30(41)26-10-8-20(31)11-13-37(26)28(39)17-36-16-23(29(32)40)21-14-19(7-9-24(21)36)22-15-33-38-12-3-5-25(22)38/h2,4,6-7,9,14-16,20,26H,3,5,8,10-13,17H2,1H3,(H2,32,40)(H,34,35,41)/t20?,26-/m0/s1	IGEANTNDOCSTDU-GHZUAHJPSA-N	563231	5-(5,6-dihydro-4H- pyrrolo[1,2- b]pyrazol-3-yl)-1- (2-((2S)-5-fluoro-2- ((6-methylpyridin- 2- yl)carbamoyl)aze- pan-1-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US11407738, Example 00406	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563231&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623988	472624771							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190134	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C27H24BrF4N9O3/c1-14(42)24-17-10-16(38-7-8-39-22(12-38)35-36-26(39)27(30,31)32)5-6-18(17)41(37-24)13-23(43)40-11-15(29)9-19(40)25(44)34-21-4-2-3-20(28)33-21/h2-6,10,15,19H,7-9,11-13H2,1H3,(H,33,34,44)/t15-,19+/m1/s1	XCOCBUFCLOAILW-BEFAXECRSA-N	386315	(2S,4R)-1-(2-(3- acetyl-5-(3- (trifluoromethyl)- 5,6-dihydro- [1,2,4]triazolo[4,3- a]pyrazin-7(8H)- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 244::US10822352, Comp No. 244::US11407738, Example 00407	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386315	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386315&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643027	404855472							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190135	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C34H28ClF5N8O3/c1-18(49)31-23-14-20(45-11-12-46-28(16-45)42-43-33(46)34(38,39)40)9-10-26(23)48(44-31)17-29(50)47-15-19(36)13-27(47)32(51)41-25-8-4-6-22(30(25)37)21-5-2-3-7-24(21)35/h2-10,14,19,27H,11-13,15-17H2,1H3,(H,41,51)/t19-,27+/m1/s1	LQPIYWGRJBQSAT-WINIVTDRSA-N	563153	(2S,4R)-1-(2-(3- acetyl-5-(3- (trifluoromethyl)- 5,6-dihydro- [1,2,4]triazolo[4,3- a]pyrazin-7(8H)- yl)-1H-indazol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Cmpd No. 531::US11407738, Example 00408	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563153&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149112	472624694							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190136	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1C[C@H]2CCCC[C@H]2C1	InChI=1S/C36H36ClF2N5O3/c1-21(45)35-28-16-25(42-17-22-7-2-3-8-23(22)18-42)13-14-31(28)44(41-35)20-33(46)43-19-24(38)15-32(43)36(47)40-30-12-6-10-27(34(30)39)26-9-4-5-11-29(26)37/h4-6,9-14,16,22-24,32H,2-3,7-8,15,17-20H2,1H3,(H,40,47)/t22-,23+,24-,32+/m1/s1	RFRPQSVYEWXECX-KSUBRIHNSA-N	563234	(2S,4R)-1-(2-(3- acetyl-5- ((3aR,7aS)- hexahydro-H- isoindol-2(3H)-yl)- 1H-indazol-1- yl)acetyl)-N-(2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00409	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563234&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149138	472624773							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190137	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)N1C[C@H]2CCCC[C@H]2C1	InChI=1S/C29H32BrFN6O3/c1-17(38)28-22-12-21(35-13-18-5-2-3-6-19(18)14-35)9-10-23(22)37(34-28)16-27(39)36-15-20(31)11-24(36)29(40)33-26-8-4-7-25(30)32-26/h4,7-10,12,18-20,24H,2-3,5-6,11,13-16H2,1H3,(H,32,33,40)/t18-,19+,20-,24+/m1/s1	WVYSAMPORZFOKM-ZSTWQFLISA-N	563235	(2S,4R)-1-(2-(3- acetyl-5- ((3aR,7aS)- hexahydro-1H- isoindol-2(3H)-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00410	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563235&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149173	472624774							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190138	COP(=O)(CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1)OC	InChI=1S/C28H28BrFN7O6P/c1-16-31-11-18(12-32-16)17-7-8-21-20(9-17)27(23(38)15-44(41,42-2)43-3)35-37(21)14-26(39)36-13-19(30)10-22(36)28(40)34-25-6-4-5-24(29)33-25/h4-9,11-12,19,22H,10,13-15H2,1-3H3,(H,33,34,40)/t19-,22+/m1/s1	ODQJAXSGLYGHEO-KNQAVFIVSA-N	563165	US11407738, Example 00340::US11407738, Example 00414::dimethyl (2-(1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrimidin-5- yl)-1H-indazol-3- yl)-2- oxoethyl)phos- phonate	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563165&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135178850	472624705							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190139	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(=O)CP(O)(O)=O)c2c1	InChI=1S/C26H24BrFN7O6P/c1-14-29-9-16(10-30-14)15-5-6-19-18(7-15)25(21(36)13-42(39,40)41)33-35(19)12-24(37)34-11-17(28)8-20(34)26(38)32-23-4-2-3-22(27)31-23/h2-7,9-10,17,20H,8,11-13H2,1H3,(H,31,32,38)(H2,39,40,41)/t17-,20+/m1/s1	FXIQIBCDWNAKQU-XLIONFOSSA-N	563166	(2-(1-(2-((2S,4R)- 2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrimidin-5- yl)-1H-indazol-3- yl)-2- oxoethyl)phosphonic acid::US11407738, Example 00341::US11407738, Example 00415	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563166&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149094	472624706							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190140	CC(=O)c1nn(CP(O)(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H24BrFN7O4P/c1-14(35)24-19-8-16(17-10-28-15(2)29-11-17)6-7-20(19)33(32-24)13-39(37,38)34-12-18(27)9-21(34)25(36)31-23-5-3-4-22(26)30-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,37,38)(H,30,31,36)/t18-,21+/m1/s1	BXLZOKHXDQDWRG-NQIIRXRSSA-N	563167	((3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)methyl)((2S,4R)- 2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin-1- yl)phosphinic acid::US11407738, Example 00342::US11407738, Example 00416	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563167&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149098	472624707							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190141	CCOP(=O)(OCC)OC[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN7O7P/c1-5-45-48(44,46-6-2)47-18-32-13-25(31(43)37-28-9-7-8-27(33)36-28)40(26(32)14-32)29(42)17-39-24-11-10-21(22-15-34-20(4)35-16-22)12-23(24)30(38-39)19(3)41/h7-12,15-16,25-26H,5-6,13-14,17-18H2,1-4H3,(H,36,37,43)/t25-,26-,32+/m0/s1	AJSNKKKHCUFVIG-RCXVBCEZSA-N	563200	((1S,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-((6- bromopyridin-2- yl)carbamoyl)-2- azabicyclo[3.1.0]hex- an-5-yl)methyl diethyl phosphate::US11407738, Example 00375::US11407738, Example 00417	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563200&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623745	472624740							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190142	CCOP(=O)(OCC)OC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN7O7P/c1-5-45-48(44,46-6-2)47-18-32-13-25(31(43)37-28-9-7-8-27(33)36-28)40(26(32)14-32)29(42)17-39-24-11-10-21(22-15-34-20(4)35-16-22)12-23(24)30(38-39)19(3)41/h7-12,15-16,25-26H,5-6,13-14,17-18H2,1-4H3,(H,36,37,43)/t25-,26+,32-/m0/s1	AJSNKKKHCUFVIG-BKQYKDOASA-N	563201	((1R,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-((6- bromopyridin-2- yl)carbamoyl)-2- azabicyclo[3.1.0]hex- an-5-yl)methyl diethyl phosphate::US11407738, Example 00376::US11407738, Example 00418	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563201&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623952	472624741							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190143	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2CNCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27ClF2N6O2/c1-16(38)28-23-8-18(20-11-33-17(2)34-12-20)6-7-25(23)37(35-28)15-26(39)36-14-21(30)9-22(36)13-32-10-19-4-3-5-24(29)27(19)31/h3-8,11-12,21-22,32H,9-10,13-15H2,1-2H3/t21-,22+/m1/s1	LLTZQBFBQQCVHZ-YADHBBJMSA-N	563241	2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-2- (((3-chloro-2- fluorobenzyl)amino) methyl)-4- fluoropyrrolidin-1- yl)ethan-1-one::US11407738, Example 00419	Complement factor D	Human		 5500							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563241&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624042	472624775							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190144	CC(O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C21H22FN5O4/c1-11(28)20-16-5-13(14-7-23-12(2)24-8-14)3-4-17(16)27(25-20)10-19(29)26-9-15(22)6-18(26)21(30)31/h3-5,7-8,11,15,18,28H,6,9-10H2,1-2H3,(H,30,31)/t11?,15-,18+/m1/s1	NYLREVJUQISCGE-HLSDDEKHSA-N	563242	(2S,4R)-4-fluoro-1- (2-(3-(1- hydroxyethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxylic acid::US11407738, Example 00420	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563242&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623977	472624776							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190145	CC(=O)c1nn(CC(=O)N2C3C[C@@H]3C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C22H21N5O4/c1-11(28)21-16-5-13(15-8-23-12(2)24-9-15)3-4-17(16)26(25-21)10-20(29)27-18-6-14(18)7-19(27)22(30)31/h3-5,8-9,14,18-19H,6-7,10H2,1-2H3,(H,30,31)/t14-,18?,19+/m1/s1	NAWJSZRMUGGVCC-ONZWQQIVSA-N	563170	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-2- azabicyclo[3.1.0]hex- ane-3-carboxylic acid::US11407738, Example 00345::US11407738, Example 00421	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563170&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135179366	472624710							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190146	COC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C22H24FN5O4/c1-12(29)21-17-6-14(15-8-24-13(2)25-9-15)4-5-18(17)28(26-21)11-20(30)27-10-16(23)7-19(27)22(31)32-3/h4-6,8-9,12,16,19,29H,7,10-11H2,1-3H3/t12?,16-,19+/m1/s1	QTYZRLMSHOQDBV-HDPDCCELSA-N	563173	(2S,4R)-methyl 4- fluoro-1-(2-(3-(1- hydroxyethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxylate::US11407738, Example 00348::US11407738, Example 00422	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563173&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149089	472624713							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190147	COc1cc(CC(=O)N2C[C@H](F)CC2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)cc(c1)-c1cnc(C)nc1	InChI=1S/C31H27ClF2N4O3/c1-18-35-15-21(16-36-18)20-10-19(11-23(13-20)41-2)12-29(39)38-17-22(33)14-28(38)31(40)37-27-9-5-7-25(30(27)34)24-6-3-4-8-26(24)32/h3-11,13,15-16,22,28H,12,14,17H2,1-2H3,(H,37,40)/t22-,28?/m1/s1	WDCCUEZRUWGNBJ-WZOMIXFGSA-N	563245	(4R)-N-(2'-chloro- 2-fluoro-[1,1'- biphenyl]-3-yl)-4- fluoro-1-(2-(3- methoxy-5-(2- methylpyrimidin-5- yl)phenyl)acetyl) pyrrolidine-2- carboxamide::US11407738, Example 00423	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563245&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149166	472624777							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190148	NC(=O)c1cc(-c2ccco2)n(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)n1	InChI=1S/C20H18BrFN6O4/c21-16-4-1-5-17(24-16)25-20(31)14-7-11(22)9-27(14)18(29)10-28-13(15-3-2-6-32-15)8-12(26-28)19(23)30/h1-6,8,11,14H,7,9-10H2,(H2,23,30)(H,24,25,31)/t11-,14+/m1/s1	BSMRBJVZGJQTFC-RISCZKNCSA-N	563246	1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (furan-2-yl)-1H- pyrazole-3- carboxamide::US11407738, Example 00424	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563246&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623957	472624778							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190149	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(-c3ccc4scnc4c3)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H27F2N7O3S/c1-18(44)33-25-10-20(22-13-37-19(2)38-14-22)6-8-28(25)43(41-33)16-31(45)42-15-23(35)12-29(42)34(46)40-26-5-3-4-24(32(26)36)21-7-9-30-27(11-21)39-17-47-30/h3-11,13-14,17,23,29H,12,15-16H2,1-2H3,(H,40,46)/t23-,29+/m1/s1	GSBBDMCXYSFHNW-BTYSJIOQSA-N	563247	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- (benzo[d]thiazol-5- yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00425	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563247&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149171	472624779							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190150	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(-c3ccc4scnc4c3)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C36H28F2N8O3S/c1-19-10-32-39-14-23(15-46(32)42-19)21-6-8-29-26(11-21)35(20(2)47)43-45(29)17-33(48)44-16-24(37)13-30(44)36(49)41-27-5-3-4-25(34(27)38)22-7-9-31-28(12-22)40-18-50-31/h3-12,14-15,18,24,30H,13,16-17H2,1-2H3,(H,41,49)/t24-,30+/m1/s1	KGSGSNZEEPKZRS-HLADLETHSA-N	563248	(2S,4R)-1-(2-(3- acetyl-5-(4- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(3- (benzo[d]thiazol-5- yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00426	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563248&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135149091	472624780							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190151	Cc1cc2ncc(cn2n1)-c1nc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)NC3CCC(C3)c3cc4sccc4s3)nc(C(N)=O)c2s1	InChI=1S/C30H28FN9O3S3/c1-14-6-23-33-10-16(11-39(23)36-14)30-35-28-26(46-30)25(27(32)42)37-40(28)13-24(41)38-12-17(31)8-19(38)29(43)34-18-3-2-15(7-18)21-9-22-20(45-21)4-5-44-22/h4-6,9-11,15,17-19H,2-3,7-8,12-13H2,1H3,(H2,32,42)(H,34,43)/t15?,17-,18?,19+/m1/s1	OLXBDVZPOLGZJT-IOXAMRCBSA-N	563249	1-(2-((2S,4R)-4- fluoro-2-((3- (thieno[3,2- b]thiophen-2- yl)cyclopentyl)carba- mothioyl)pyrrolidin- 1-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-pyrazolo[3,4- d]thiazole-3- carboxamide::US11407738, Example 00427	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563249&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135178853	472624781							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190152	Cc1ncc(cn1)-c1nc2c(nn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)NC3CCC(C3)c3cc4sccc4s3)c2s1)C(N)=O	InChI=1S/C28H27FN8O3S3/c1-13-31-9-15(10-32-13)27-34-24-23(25(30)39)35-37(28(24)43-27)12-22(38)36-11-16(29)7-18(36)26(40)33-17-3-2-14(6-17)20-8-21-19(42-20)4-5-41-21/h4-5,8-10,14,16-18H,2-3,6-7,11-12H2,1H3,(H2,30,39)(H,33,40)/t14?,16-,17?,18+/m1/s1	NFFMAKQUFQGBKC-CCRGXQTGSA-N	563250	1-(2-((2S,4R)-4- fluoro-2-((3- (thieno[3,2- b]thiophen-2- yl)cyclopentyl)carba- mothioyl)pyrrolidin- 1-yl)-2- oxoethyl)-5-(2- methylpyrimdin-5- yl)-1H- pyrazolo[4,3- d]thiazole-3- carboxamide::US11407738, Example 00428	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563250&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			154627623	472624782							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190153	CC(=O)c1nn(CC(=O)N2CCC[C@H](C2)C(=O)NCc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H28BrN7O3/c1-17(37)27-23-11-19(21-12-30-18(2)31-13-21)8-9-24(23)36(34-27)16-26(38)35-10-4-5-20(15-35)28(39)32-14-22-6-3-7-25(29)33-22/h3,6-9,11-13,20H,4-5,10,14-16H2,1-2H3,(H,32,39)/t20-/m1/s1	BGHYVSLVCDLILP-HXUWFJFHSA-N	563251	(R)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((6- bromopyridin-2- yl)methyl)piperidine- 3-carboxamide::US11407738, Example 00429	Complement factor D	Human		>10000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563251&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623887	472624783							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1190154	CC(=O)c1cc(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)n2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15(36)21-10-20(34-7-6-17(8-22(21)34)18-12-30-16(2)31-13-18)11-26(37)35-14-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10,12-13,19,23H,9,11,14H2,1-2H3,(H,32,33,38)/t19-,23+/m1/s1	SBPBVIBTPMISMH-XXBNENTESA-N	563252	(2S,4R)-1-(2-(1- acetyl-7-(2- methylpyrimidin-5- yl)indolizin-3- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00430	Complement factor D	Human		<1000							US Patent		10.7270/Q2MC937S		aid1806712	US11407738	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Greenlee, W	8/9/2022	10/28/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=563252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=563252&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623902	472624784							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4